Prevalence of germline TP53 mutations in HER2+ breast cancer patients

By Rath Michelle  

Breast Cancer Research and Treatment, Vol. 139, Iss. 1, 2013-05 ,pp. : 193-198

Springer Publishing Company

Access to resources Recommend Favorite

A comparison between p53 accumulation determined by immunohistochemistry and TP53 mutations as prognostic variables in tumours from breast cancer patients

By Alsner Jan   Jensen Vibeke   Kyndi Marianne   Vrou Offersen Birgitte   Vu Phuong   Børresen-Dale Anne-Lise   Overgaard Jens  

Acta Oncologica, Vol. 47, Iss. 4, 2008-01 ,pp. : 600-607

Informa Healthcare

Access to resources Recommend Favorite

RAS, BRAF, and TP53 Gene Mutations in Taiwanese Colorectal Cancer Patients

By  

Onkologie, Vol. 36, Iss. 12, 2013-11 ,pp. : 719-724

Karger

Access to resources Recommend Favorite

Association between TP53 and p21 genetic polymorphisms and acute side effects of radiotherapy in breast cancer patients

By Tan Xiang-Lin   Popanda Odilia   Ambrosone Christine   Kropp Silke   Helmbold Irmgard   Fournier Dietrich   Haase Wulf   Sautter-Bihl Marie   Wenz Frederik   Schmezer Peter   Chang-Claude Jenny  

Breast Cancer Research and Treatment, Vol. 97, Iss. 3, 2006-06 ,pp. : 255-262

Springer Publishing Company

Access to resources Recommend Favorite

Breast cancer phenotype in women with TP53 germline mutations: a Li-Fraumeni syndrome consortium effort

By Masciari Serena  

Breast Cancer Research and Treatment, Vol. 133, Iss. 3, 2012-06 ,pp. : 1125-1130

Springer Publishing Company

Access to resources Recommend Favorite